Inhibitory effect of Aspergillus fumigatus extract on matrix metalloproteinases expression

Mycopathologia

Volumn 158, Issue 1, 2004, Pages 33-37

  Saadat, Farshid ^a   Zomorodian, Kamiar ^b   Pezeshki, Mohammad ^a   Rezaie, Sassan ^b   Khorramizadeh, Mohammad Reza ^a  

^a Dept Med Mycol Parasitol S ^*

^b Sch Pub Hlth Inst Pub Hlth R   (Iran)

Author keywords

Aspergillus fumigatus; cancer; cytotoxicity; matrix metalloproteinase; zymoanalysis

Indexed keywords

DEXAMETHASONE; DICLOFENAC; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ARTICLE; ASPERGILLUS FUMIGATUS; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; FIBROSARCOMA; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPERGILLUS FUMIGATUS; CELL LINE, TUMOR; DEXAMETHASONE; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASES; PIROXICAM;

ASPERGILLUS; ASPERGILLUS FUMIGATUS;

EID: 4444231079     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MYCO.0000038429.46699.ac     Document Type: Article

References (29)

1. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
2. Edwards, DR, Beaudry PP et al. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes 1996; 20: S9-S15.
3. Cunnane G, Fitzgerald O et al. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3 and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum 2001; 44(10): 2263-2274.
4. Katrib A, Tak PP et al. Expression of chemokines matrix metalloproteinases in early rheumatoid arthritis. Rheumatology (Oxford) 2001; 40(9): 988-994
5. Cunnane G, Fitzgerald O et al. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 2001; 44(8): 1744-1753.
6. Bluteau G, Conrozier T et al. Matrix metalloproteinase-1, - 3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 2001; 1526(2): 147-158.
7. Massova I, Kotra LP et al. Matrix metalloproteinases : Structures, evolution, and diversification. FASEB J 1998; 12: 1075-1095.
8. Sanchez-Lopez R, Alexander CM et al. Role of zinc-binding-and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins. J Biol Chem 1993; 268: 7238-7247.
9. Gross, J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U. S. A. 1962; 48: 1014-1022.
10. Imbert C, Kauffmann-Lacroix C, Daniault G, Jacquemin JL, Rodier MH. Effect of matrix metalloprotease inhibitors on the 95 kDa metallopeptidase of Candida albicans. J Antimicrob Chemother. 2002 June; 49(6): 1007-1010.
11. Gopinathan U, Ramakrishna T, Willcox M, Rao CM, Balasubramanian D, Kulkarni A, Vemuganti GK, Rao GN. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res. 2001 April; 72(4): 433-442.
12. Lovejoy B, Cleasby A et al. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 1994; 263: 375-377.
13. Zaini F, Moore MK et al. The antigenic composition and protein profiles of cumycetoma agents. Mycoses 1991; 34: 19-28.
14. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
16. Hudson L, Hay FC. Practical Immunology. Blackwell Scientific Publications, Oxford, 1991: 65-70.
17. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry 1980; 102: 196-202.
18. Thant AA, Serbulea M et al. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Letters 1997; 406: 28-30.
19. Fidler IJ. Molecular biology of cancer: invasion and metastasis. In Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: IB Lippincott Co, 1997: 135-152.
20. Stetler-Stevenson, WG, Hewitt R et al. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 1996; 7: 147-154.
21. Jones L, Ghaneh P et al. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann New York Acad Sci 1999; 880: 288-307.
22. Drummond AH, Bekette P et al. Preclinical and clinical studies of MMP inhibitors in cancer. Ann New York Acad Sci 1999; 878: 228-235.
23. John A, Tuszynski G. The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7(1): 14-23.
24. Nguyen M, Arkell J et al. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001; 33(10): 960-970.
25. Rodier MH, el Moudni B, Kauffmann-Lacroix C, Daniault G, Jacquemin JL. A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix. FEMS Microbiol Lett. 1999; 177(2): 205-210.
26. Inokoshi J, Shiomi K et al. Funalenone, a novel collagenase inhibitor produced by Aspergillus niger. J Antibiot 1999; 52(12): 1095-1100.
27. Eberhardt W, Schulze M et al. Glucocorticoid-mediated suppression of Cytokine-induced matrix metalloproteinase-9 expression in Rat mesangial cells: involvment of nuclear factor - kappaB and Ets transcription factors. Mol Endocrinol 2002; 16(8): 1752-1766.
28. Pross C, Farooq MM et al. Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. J Surg Res 2002; 102(2): 57-62.
29. Sadowski T, Steinmeyer J. Effects of non-steroidal anti-inflammatory drugs and Dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage 2001; 9(5): 407-415.